Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Kätkä

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Scandinavian Journal of Haematology|January 1, 1984
Immune functions in pernicious anaemia before and during treatment with vitamin B12K Kätkä
Acta Endocrinologica|February 1, 1992
Dramatic response of a metastatic carcinoid tumour to a combination of interferon and octreotideH Joensuu, K Kätkä, H Kujari
Dermatologica|January 1, 1984
Monoclonal IgG immunoglobulinemia with subsequent myeloma in psoriatic arthritisL Peltonen, E Nikoskelainen, K Kätkä, et al.
Clinical Immunology and Immunopathology|January 1, 1988
Serum IgA deficiency and anti-IgA antibodies in pernicious anemiaK Kätkä, J Eskola, K Granfors, et al.
British Journal of Haematology|January 1, 1983
Granulocyte function in untreated pernicious anaemiaK Kätkä, R A Seger, T Matsunaga, et al.
Bone Marrow Transplantation|September 1, 1988
Allogeneic bone marrow transplantation in multiple myeloma: a report of four casesJ Nikoskelainen, K Koskela, K Kätkä, et al.
Vox Sanguinis|January 1, 1995
Tolerability and kinetics of a solvent-detergent-treated intravenous immunoglobulin preparation in hypogammaglobulinaemia patientsF Ebeling, M Baer, P Hormila, et al.
European Journal of Haematology|September 1, 1991
Value of maintenance therapy with chemotherapy or interferon during remission of acute myeloid leukaemiaI P Palva, A Almqvist, E Elonen, et al.
Leukemia Research|February 1, 1997
Intensive chemotherapy of poor prognosis myelodysplastic syndromes (MDS) and acute myeloid leukemia following MDS with idarubicin and cytarabineT Ruutu, A Hänninen, G Järventie, et al.
Leukemia & Lymphoma|July 27, 2016
Effect of the Choice of Primary Chemotherapy on the Cumulative Length of Stay in Hospital for Multiple MyelomaI P Palva, P Ahrenberg, K Ala-Harja, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Scandinavian Journal of Haematology|January 1, 1984
Immune functions in pernicious anaemia before and during treatment with vitamin B12K Kätkä
Acta Endocrinologica|February 1, 1992
Dramatic response of a metastatic carcinoid tumour to a combination of interferon and octreotideH Joensuu, K Kätkä, H Kujari
Dermatologica|January 1, 1984
Monoclonal IgG immunoglobulinemia with subsequent myeloma in psoriatic arthritisL Peltonen, E Nikoskelainen, K Kätkä, et al.
Clinical Immunology and Immunopathology|January 1, 1988
Serum IgA deficiency and anti-IgA antibodies in pernicious anemiaK Kätkä, J Eskola, K Granfors, et al.
British Journal of Haematology|January 1, 1983
Granulocyte function in untreated pernicious anaemiaK Kätkä, R A Seger, T Matsunaga, et al.
Bone Marrow Transplantation|September 1, 1988
Allogeneic bone marrow transplantation in multiple myeloma: a report of four casesJ Nikoskelainen, K Koskela, K Kätkä, et al.
Vox Sanguinis|January 1, 1995
Tolerability and kinetics of a solvent-detergent-treated intravenous immunoglobulin preparation in hypogammaglobulinaemia patientsF Ebeling, M Baer, P Hormila, et al.
European Journal of Haematology|September 1, 1991
Value of maintenance therapy with chemotherapy or interferon during remission of acute myeloid leukaemiaI P Palva, A Almqvist, E Elonen, et al.
Leukemia Research|February 1, 1997
Intensive chemotherapy of poor prognosis myelodysplastic syndromes (MDS) and acute myeloid leukemia following MDS with idarubicin and cytarabineT Ruutu, A Hänninen, G Järventie, et al.
Leukemia & Lymphoma|July 27, 2016
Effect of the Choice of Primary Chemotherapy on the Cumulative Length of Stay in Hospital for Multiple MyelomaI P Palva, P Ahrenberg, K Ala-Harja, et al.
Pageof 1